According to the research report “Global Disposable Syringes Market Outlook, 2030” published by Bonafide Research, the global Disposable Syringes market is projected to reach market size of USD 14.51 Billion by 2030 increasing from USD 9.98 Billion in 2024, growing with 6.57% CAGR by 2025-30.

Top Six Companies Global Disposable Syringes Market

B. Braun Melsungen SE: B. Braun Melsungen AG develops, manufactures, and distributes medical technology and pharmaceutical products, and provides medical services. The company develops, manufactures, and distributes over 5,000 products for hospitals, practitioners, and home care, focusing on improving patient safety and clinical outcomes. The company operates through four main segments: Hospital Care, Aesculap (surgical instruments/implants), Outpatient Market, and Avitum (dialysis). The company has a presence in Europe, the Americas, Asia-Pacific, Africa, and the Middle East, B. Braun maintains extensive production facilities and subsidiaries worldwide.The company emphasizes working with healthcare professionals to develop integrated, sustainable solutions.Their portfolio includes 2-piece and 3-piece syringes made primarily from highly transparent polypropylene (PP), designed for various applications including injection, aspiration, and infusion.

• Established: 1839

• Headquarters: Melsungen, Germany

• Employees: 64,000

• Revenue: USD 10,773 Million

Becton, Dickinson and Company: Becton Dickinson and Co is a medical technology company. It manufactures and distributes medical supplies, devices, laboratory equipment, and diagnostic products. The company's product portfolio includes vascular and urology devices, surgical products, molecular diagnostic systems, infusion pumps, pre-fillable drug delivery systems, hemodynamic monitoring tools, and cell analysis solutions. BD's products serve healthcare institutions, physicians, life science researchers, clinical labs, the pharmaceutical sector, and the general public. The company has manufacturing operations in various countries, including Bosnia and Herzegovina, Brazil, Canada, the US, the Dominican Republic, France, Germany, Hungary, India, Japan, Mexico and others. BD is headquartered in Franklin Lakes, New Jersey, the US. As a global leader in disposable syringes, recognized for producing high-quality, sterile, single-use, and, in many cases, latex-free devices used for accurate medication delivery, vaccination, and blood collection. Key products include BD Plastipak™ 3-piece syringes and safety-engineered syringes, featuring clear barrels, precise markings, and secure Luer-Lok™ or slip tips.

• Established: 1897

• Headquarters: New Jersey, U.S.

• Employees: 75,000

• Revenue: USD 21,840 Million

Nipro Corporation: Nipro Corp develops, manufactures, and distributes medical devices, pharmaceuticals, and pharmaceutical packaging. The company’s products include renal products, interventional and anaesthesiology products, injection and infusion products, cardiopulmonary products, double bags, pre-filled syringes, and half-type kits among others. It offers contract manufacturing services of development, manufacturing of drug formulations, inspection, packaging, logistics and distribution services. Nipro also provides glass molding vials, ampoules, syringes, and cartridges; glass tubes for pharmaceuticals; glass-forming machinery; other parts of pharmaceutical packaging including rubber plugs; and glass bulbs for vacuum flasks. The company has sales offices in North America, South America, Europe, Asia, and Africa. Nipro is headquartered in Settsu, Osaka, Japan.Nipro Corporation offers a diverse portfolio of high-quality, sterile, and single-use disposable syringes designed for hospitals, clinics, and home use. Their syringes feature clear polypropylene barrels with bold markings, smooth plunger action, and various tips (Luer lock, slip, eccentric) to ensure accurate medication delivery

• Established: 1954

• Headquarters: Osaka, Japan

• Employees: 38,000

• Revenue: USD 4,159 Million

Terumo Corporation: Terumo Corp (Terumo) is a medical technology company. Its primary activities include the manufacture and sales of medical products and equipment, with a focus on vascular intervention, cardio-surgical solutions, blood transfusion and cell therapy technology, and daily clinical practice essentials. Terumo's product portfolio includes pharmaceuticals, blood bags, disposable medical devices, cardiovascular systems, vascular grafts, peritoneal dialysis, blood glucose monitoring systems, medical electronics, and digital thermometers. The company operates through several divisions, including Terumo Interventional Systems, MicroVention, Terumo Cardiovascular, and Terumo Aortic. Terumo's products are used by medical professionals in various healthcare settings, with applications ranging from cardiac surgery to diabetes care.Terumo Corporation offers a widely used, high-quality line of 3-part disposable syringes (1 mL to 60 mL) featuring clear polypropylene barrels, bold markings, and smooth-operating, latex-free gaskets. Designed for precision, safety, and comfort, these syringes are available with Luer Lock, Luer Slip, or catheter tips, often featuring integrated plunger stops. 

• Established: 1921

• Headquarters: Tokyo, Japan

• Employees: 30,000

• Revenue: USD 6,686 Million

Cardinal Health Inc: Cardinal Health Inc (Cardinal Health) is a provider of integrated healthcare products and services. The company's main activities include the distribution of pharmaceuticals, manufacturing and distribution of medical and laboratory products, and providing performance and data solutions for healthcare facilities. It distributes branded and generic drugs, specialty medicines, over-the-counter healthcare and consumer products, medical equipment, surgical devices and laboratory products. It also operates nuclear pharmacies and cyclotron facilities and manufactures its own line of private branded medical and surgical products. Its clientele includes retail customers such as chain and independent drug stores and pharmacies in supermarkets and mass merchandisers, hospitals, ambulatory care centers, physician offices, clinical laboratories and alternative care providers including mail order customers. The company operates in the US, Canada, Australia, China and Japan. Cardinal Health is headquartered in Dublin, Ohio, the US. The company offers a comprehensive portfolio of disposable syringes, primarily branded under the Monoject™ line, designed for safety, precision, and efficiency in clinical settings. Their offering includes hypodermic safety needles, Magellan™ safety needles, insulin/tuberculin syringes, and blunt fill needles, with 90% manufactured in the U.S. to ensure high quality and reduce needlestick injuries.

• Established: 1971

• Headquarters: Ohio, U.S.

• Employees: 50,000

• Revenue: USD 2,22,600 Million

Fresenius SE & Co. KGaA: Fresenius SE & Co KGaA (Fresenius) is a global healthcare company that offers products and services for dialysis, hospitals, and outpatient treatment. It provides various dialysis services through its own clinics and markets products to other dialysis service providers. The company's major products and services include machines for hemodialysis, acute dialysis and peritoneal dialysis; solutions for infusion therapy; dialysis care services; liver support therapy services; and provision projects and services for hospitals and other health care facilities. It also operates and manages acute care and post-acute care hospitals in Germany through Helios Kliniken Group. Fresenius conducts operations in Europe, Asia-Pacific, Africa and the Americas. The company is headquartered in Bad Homburg, Hessen, Germany.Fresenius SE & Co. KGaA, primarily through its Fresenius Kabi subsidiary, is a major manufacturer of advanced, ready-to-administer (RTA) prefilled syringes, rather than basic, disposable, empty syringes. Their portfolio focuses on improving safety, reducing medication waste, and enhancing efficiency in clinical settings like hospitals and operating rooms. 

• Established: 1912

• Headquarters: Bad Homburg, Germany

• Employees: 176,486

• Revenue: USD 25,360 Million